Zynex Ownership
| ZYXI Stock | USD 2.90 0.07 2.36% |
Shares in Circulation | First Issued 1998-03-31 | Previous Quarter 32.1 M | Current Value 32.2 M | Avarage Shares Outstanding 30.2 M | Quarterly Volatility 10.7 M |
Zynex |
Zynex Stock Ownership Analysis
About 51.0% of the company outstanding shares are owned by insiders. The book value of Zynex was at this time reported as 1.12. The company last dividend was issued on the 5th of January 2022. Zynex Inc had 11:10 split on the 5th of January 2022. Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Zynex operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 774 people. For more information please call Thomas Sandgaard at (800) 495-6670 or visit https://www.zynex.com.Besides selling stocks to institutional investors, Zynex also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Zynex's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Zynex's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Zynex Quarterly Liabilities And Stockholders Equity |
|
Zynex Insider Trades History
About 51.0% of Zynex Inc are currently held by insiders. Unlike Zynex's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Zynex's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Zynex's insider trades
Zynex Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Zynex is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zynex Inc backward and forwards among themselves. Zynex's institutional investor refers to the entity that pools money to purchase Zynex's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Janney Montgomery Scott Llc | 2024-12-31 | 159.3 K | Northern Trust Corp | 2024-12-31 | 156.8 K | D. E. Shaw & Co Lp | 2024-12-31 | 141.6 K | Renaissance Technologies Corp | 2024-12-31 | 137.4 K | Congress Asset Management Company, Llp | 2024-12-31 | 121.5 K | Two Sigma Advisers, Llc | 2024-12-31 | 121 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 110.4 K | Crédit Agricole S.a. | 2024-12-31 | 110.2 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 99.5 K | Blackrock Inc | 2024-12-31 | 1.2 M | Vanguard Group Inc | 2024-12-31 | 1.1 M |
Zynex Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zynex insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zynex's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zynex insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zynex Outstanding Bonds
Zynex issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zynex Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zynex bonds can be classified according to their maturity, which is the date when Zynex Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US98981BAA08 Corp BondUS98981BAA08 | View | |
| US98980BAA17 Corp BondUS98980BAA17 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Zynex Corporate Filings
8K | 17th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 0.09 | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.